The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Cancer Stem Cells-Global Market Insights and Sales Trends 2024
Synopsis
Cancer stem cells (CSCs) are cancer cells (found within tumors or hematological cancers) that possess characteristics associated with normal stem cells, specifically the ability to give rise to all cell types found in a particular cancer sample.
The global Cancer Stem Cells market size is expected to reach US$ 1917.8 million by 2029, growing at a CAGR of 12.0% from 2023 to 2029. The market is mainly driven by the significant applications of Cancer Stem Cells in various end use industries. The expanding demands from the Breast Cancer Diagnosis and Treatment, Prostate Cancer Diagnosis and Treatment, Colorectal Cancer Diagnosis and Treatment and Lung Cancer Diagnosis and Treatment, are propelling Cancer Stem Cells market. Cell Culturing, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Cell Separation segment is estimated at % CAGR for the next seven-year period.
Over the past few years, stem cells are being successfully utilized in immuno-reconstitution and for replenishment of blood after tumor development or after tumor treatment.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Cancer Stem Cells, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Cancer Stem Cells market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Cancer Stem Cells market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Cancer Stem Cells sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Cancer Stem Cells covered in this report include Thermo Fisher Scientific, Abbvie, Merck Kgaa, Bionomics, Lonza, Stemline Therapeutics, Miltenyi Biotec, Promocell and Macrogenics, etc.
The global Cancer Stem Cells market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Thermo Fisher Scientific
Abbvie
Merck Kgaa
Bionomics
Lonza
Stemline Therapeutics
Miltenyi Biotec
Promocell
Macrogenics
Oncomed Pharmaceuticals
Irvine Scientific
Stemcell Technologies
Sino Biological
Biotime
Global Cancer Stem Cells market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Cancer Stem Cells market, Segment by Type:
Cell Culturing
Cell Separation
Cell Analysis
Molecular Analysis
Others
Global Cancer Stem Cells market, by Application
Breast Cancer Diagnosis and Treatment
Prostate Cancer Diagnosis and Treatment
Colorectal Cancer Diagnosis and Treatment
Lung Cancer Diagnosis and Treatment
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Cancer Stem Cells companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Cancer stem cells (CSCs) are cancer cells (found within tumors or hematological cancers) that possess characteristics associated with normal stem cells, specifically the ability to give rise to all cell types found in a particular cancer sample.
The global Cancer Stem Cells market size is expected to reach US$ 1917.8 million by 2029, growing at a CAGR of 12.0% from 2023 to 2029. The market is mainly driven by the significant applications of Cancer Stem Cells in various end use industries. The expanding demands from the Breast Cancer Diagnosis and Treatment, Prostate Cancer Diagnosis and Treatment, Colorectal Cancer Diagnosis and Treatment and Lung Cancer Diagnosis and Treatment, are propelling Cancer Stem Cells market. Cell Culturing, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Cell Separation segment is estimated at % CAGR for the next seven-year period.
Over the past few years, stem cells are being successfully utilized in immuno-reconstitution and for replenishment of blood after tumor development or after tumor treatment.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Cancer Stem Cells, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Cancer Stem Cells market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Cancer Stem Cells market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Cancer Stem Cells sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Cancer Stem Cells covered in this report include Thermo Fisher Scientific, Abbvie, Merck Kgaa, Bionomics, Lonza, Stemline Therapeutics, Miltenyi Biotec, Promocell and Macrogenics, etc.
The global Cancer Stem Cells market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Thermo Fisher Scientific
Abbvie
Merck Kgaa
Bionomics
Lonza
Stemline Therapeutics
Miltenyi Biotec
Promocell
Macrogenics
Oncomed Pharmaceuticals
Irvine Scientific
Stemcell Technologies
Sino Biological
Biotime
Global Cancer Stem Cells market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Cancer Stem Cells market, Segment by Type:
Cell Culturing
Cell Separation
Cell Analysis
Molecular Analysis
Others
Global Cancer Stem Cells market, by Application
Breast Cancer Diagnosis and Treatment
Prostate Cancer Diagnosis and Treatment
Colorectal Cancer Diagnosis and Treatment
Lung Cancer Diagnosis and Treatment
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Cancer Stem Cells companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Cancer Stem Cells
1.1 Cancer Stem Cells Market Overview
1.1.1 Cancer Stem Cells Product Scope
1.1.2 Cancer Stem Cells Market Status and Outlook
1.2 Global Cancer Stem Cells Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Cancer Stem Cells Market Size by Region (2018-2029)
1.4 Global Cancer Stem Cells Historic Market Size by Region (2018-2023)
1.5 Global Cancer Stem Cells Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Cancer Stem Cells Market Size (2018-2029)
1.6.1 North America Cancer Stem Cells Market Size (2018-2029)
1.6.2 Europe Cancer Stem Cells Market Size (2018-2029)
1.6.3 Asia-Pacific Cancer Stem Cells Market Size (2018-2029)
1.6.4 Latin America Cancer Stem Cells Market Size (2018-2029)
1.6.5 Middle East & Africa Cancer Stem Cells Market Size (2018-2029)
2 Cancer Stem Cells Market by Type
2.1 Introduction
2.1.1 Cell Culturing
2.1.2 Cell Separation
2.1.3 Cell Analysis
2.1.4 Molecular Analysis
2.1.5 Others
2.2 Global Cancer Stem Cells Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Cancer Stem Cells Historic Market Size by Type (2018-2023)
2.2.2 Global Cancer Stem Cells Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Cancer Stem Cells Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Cancer Stem Cells Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Cancer Stem Cells Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Cancer Stem Cells Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Cancer Stem Cells Revenue Breakdown by Type (2018-2029)
3 Cancer Stem Cells Market Overview by Application
3.1 Introduction
3.1.1 Breast Cancer Diagnosis and Treatment
3.1.2 Prostate Cancer Diagnosis and Treatment
3.1.3 Colorectal Cancer Diagnosis and Treatment
3.1.4 Lung Cancer Diagnosis and Treatment
3.1.5 Others
3.2 Global Cancer Stem Cells Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Cancer Stem Cells Historic Market Size by Application (2018-2023)
3.2.2 Global Cancer Stem Cells Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Cancer Stem Cells Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Cancer Stem Cells Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Cancer Stem Cells Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Cancer Stem Cells Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Cancer Stem Cells Revenue Breakdown by Application (2018-2029)
4 Cancer Stem Cells Competition Analysis by Players
4.1 Global Cancer Stem Cells Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Cancer Stem Cells as of 2022)
4.3 Date of Key Players Enter into Cancer Stem Cells Market
4.4 Global Top Players Cancer Stem Cells Headquarters and Area Served
4.5 Key Players Cancer Stem Cells Product Solution and Service
4.6 Competitive Status
4.6.1 Cancer Stem Cells Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Thermo Fisher Scientific
5.1.1 Thermo Fisher Scientific Profile
5.1.2 Thermo Fisher Scientific Main Business
5.1.3 Thermo Fisher Scientific Cancer Stem Cells Products, Services and Solutions
5.1.4 Thermo Fisher Scientific Cancer Stem Cells Revenue (US$ Million) & (2018-2023)
5.1.5 Thermo Fisher Scientific Recent Developments
5.2 Abbvie
5.2.1 Abbvie Profile
5.2.2 Abbvie Main Business
5.2.3 Abbvie Cancer Stem Cells Products, Services and Solutions
5.2.4 Abbvie Cancer Stem Cells Revenue (US$ Million) & (2018-2023)
5.2.5 Abbvie Recent Developments
5.3 Merck Kgaa
5.3.1 Merck Kgaa Profile
5.3.2 Merck Kgaa Main Business
5.3.3 Merck Kgaa Cancer Stem Cells Products, Services and Solutions
5.3.4 Merck Kgaa Cancer Stem Cells Revenue (US$ Million) & (2018-2023)
5.3.5 Bionomics Recent Developments
5.4 Bionomics
5.4.1 Bionomics Profile
5.4.2 Bionomics Main Business
5.4.3 Bionomics Cancer Stem Cells Products, Services and Solutions
5.4.4 Bionomics Cancer Stem Cells Revenue (US$ Million) & (2018-2023)
5.4.5 Bionomics Recent Developments
5.5 Lonza
5.5.1 Lonza Profile
5.5.2 Lonza Main Business
5.5.3 Lonza Cancer Stem Cells Products, Services and Solutions
5.5.4 Lonza Cancer Stem Cells Revenue (US$ Million) & (2018-2023)
5.5.5 Lonza Recent Developments
5.6 Stemline Therapeutics
5.6.1 Stemline Therapeutics Profile
5.6.2 Stemline Therapeutics Main Business
5.6.3 Stemline Therapeutics Cancer Stem Cells Products, Services and Solutions
5.6.4 Stemline Therapeutics Cancer Stem Cells Revenue (US$ Million) & (2018-2023)
5.6.5 Stemline Therapeutics Recent Developments
5.7 Miltenyi Biotec
5.7.1 Miltenyi Biotec Profile
5.7.2 Miltenyi Biotec Main Business
5.7.3 Miltenyi Biotec Cancer Stem Cells Products, Services and Solutions
5.7.4 Miltenyi Biotec Cancer Stem Cells Revenue (US$ Million) & (2018-2023)
5.7.5 Miltenyi Biotec Recent Developments
5.8 Promocell
5.8.1 Promocell Profile
5.8.2 Promocell Main Business
5.8.3 Promocell Cancer Stem Cells Products, Services and Solutions
5.8.4 Promocell Cancer Stem Cells Revenue (US$ Million) & (2018-2023)
5.8.5 Promocell Recent Developments
5.9 Macrogenics
5.9.1 Macrogenics Profile
5.9.2 Macrogenics Main Business
5.9.3 Macrogenics Cancer Stem Cells Products, Services and Solutions
5.9.4 Macrogenics Cancer Stem Cells Revenue (US$ Million) & (2018-2023)
5.9.5 Macrogenics Recent Developments
5.10 Oncomed Pharmaceuticals
5.10.1 Oncomed Pharmaceuticals Profile
5.10.2 Oncomed Pharmaceuticals Main Business
5.10.3 Oncomed Pharmaceuticals Cancer Stem Cells Products, Services and Solutions
5.10.4 Oncomed Pharmaceuticals Cancer Stem Cells Revenue (US$ Million) & (2018-2023)
5.10.5 Oncomed Pharmaceuticals Recent Developments
5.11 Irvine Scientific
5.11.1 Irvine Scientific Profile
5.11.2 Irvine Scientific Main Business
5.11.3 Irvine Scientific Cancer Stem Cells Products, Services and Solutions
5.11.4 Irvine Scientific Cancer Stem Cells Revenue (US$ Million) & (2018-2023)
5.11.5 Irvine Scientific Recent Developments
5.12 Stemcell Technologies
5.12.1 Stemcell Technologies Profile
5.12.2 Stemcell Technologies Main Business
5.12.3 Stemcell Technologies Cancer Stem Cells Products, Services and Solutions
5.12.4 Stemcell Technologies Cancer Stem Cells Revenue (US$ Million) & (2018-2023)
5.12.5 Stemcell Technologies Recent Developments
5.13 Sino Biological
5.13.1 Sino Biological Profile
5.13.2 Sino Biological Main Business
5.13.3 Sino Biological Cancer Stem Cells Products, Services and Solutions
5.13.4 Sino Biological Cancer Stem Cells Revenue (US$ Million) & (2018-2023)
5.13.5 Sino Biological Recent Developments
5.14 Biotime
5.14.1 Biotime Profile
5.14.2 Biotime Main Business
5.14.3 Biotime Cancer Stem Cells Products, Services and Solutions
5.14.4 Biotime Cancer Stem Cells Revenue (US$ Million) & (2018-2023)
5.14.5 Biotime Recent Developments
6 North America
6.1 North America Cancer Stem Cells Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Cancer Stem Cells Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Cancer Stem Cells Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Cancer Stem Cells Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Cancer Stem Cells Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Cancer Stem Cells Market Dynamics
11.1 Cancer Stem Cells Industry Trends
11.2 Cancer Stem Cells Market Drivers
11.3 Cancer Stem Cells Market Challenges
11.4 Cancer Stem Cells Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
